Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease

Carcinogenesis
Thomas U AhearnTransdisciplinary Prostate Cancer Partnership (ToPCaP)

Abstract

Circulating insulin-like growth factor-1 (IGF-1) is consistently associated with prostate cancer risk. IGF-1 binds to IGF-1 receptor (IGF1R) and insulin receptor (IR), activating cancer hallmark pathways. Experimental evidence suggests that TMPRSS2:ERG may interact with IGF/insulin signaling to influence progression. We investigated IGF1R and IR expression and its association with lethal prostate cancer among 769 men. Protein expression of IGF1R, IR and ERG (i.e. a surrogate of ERG fusion genes) were assayed by immunohistochemistry. Cox models estimated hazard ratios (HR) and 95% confidence intervals (CI) adjusted for clinical characteristics. Among patients, 29% had strong tumor IGF1R expression and 10% had strong IR expression. During a mean follow-up of 13.2 years through 2012, 80 men (11%) developed lethal disease. Tumors with strong IGF1R or IR expression showed increased cell proliferation, decreased apoptosis and a higher prevalence of ERG. In multivariable models, strong IGF1R was associated with a borderline increased risk of lethal prostate cancer (HR 1.7; 95% CI 0.9-3.1). The association appeared greater in ERG-positive tumors (HR 2.8; 95% CI 0.9-8.4) than in ERG-negative tumors (HR 1.3; 95% CI 0.6-3.0, p-heterogenei...Continue Reading

References

Mar 1, 1985·Preventive Medicine·C H Hennekens, K Eberlein
Jul 18, 2002·Journal of the National Cancer Institute·June M ChanEdward Giovannucci
Dec 19, 2002·Journal of the National Cancer Institute·Steven LehrerRichard G Stock
Jul 2, 2004·Nature Reviews. Cancer·Michael N PollakSusan E Hankinson
Apr 28, 2006·Journal of Cellular Biochemistry·Jennifer D WuStephen R Plymate
Feb 6, 2007·International Journal of Cancer. Journal International Du Cancer·Tanja StocksPär Stattin
Apr 24, 2007·International Journal of Cancer. Journal International Du Cancer·Edward GiovannucciWalter C Willett
Jun 6, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Naomi E AllenRudolf Kaaks
Aug 5, 2008·Current Opinion in Pharmacology·Michael Pollak
Sep 12, 2008·The Prostate·Michael E CoxMichael Pollak
Nov 26, 2008·Nature Reviews. Cancer·Michael Pollak
Dec 11, 2008·JAMA : the Journal of the American Medical Association·J Michael GazianoJulie E Buring
Jan 15, 2009·International Journal of Cancer. Journal International Du Cancer·Mari-Anne RowlandsRichard M Martin
Jan 17, 2009·The Journal of Pathology·Bart RikhofWinette T A van der Graaf
May 5, 2009·European Urology·Scott A TomlinsJack A Schalken
May 13, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer R StarkLorelei A Mucci
Oct 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lorelei A MucciSteven K Clinton
May 18, 2010·International Journal of Cancer. Journal International Du Cancer·Katharina NimptschEdward Giovannucci
Sep 23, 2010·Cancer Prevention Research·Gabriel Y LaiElizabeth A Platz
Apr 6, 2011·Journal of Cellular Physiology·Aejaz SayeedLucia R Languino
Dec 21, 2011·Cancer Causes & Control : CCC·Mari-Anne RowlandsRichard M Martin
Jun 28, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Andreas PetterssonLorelei A Mucci
Jul 5, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Alison J PriceTimothy Key
Jan 16, 2013·Endocrine-related Cancer·Amy A LubikColleen C Nelson
Aug 29, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Ke ZuEdward Giovannucci
Dec 3, 2013·Journal of the National Cancer Institute·Andreas PetterssonLorelei A Mucci
Mar 26, 2014·Cancer Causes & Control : CCC·Gabriel Y LaiElizabeth A Platz
Oct 29, 2014·International Journal of Cancer. Journal International Du Cancer·Yin CaoEdward L Giovannucci
Nov 7, 2015·Cell·UNKNOWN Cancer Genome Atlas Research Network

❮ Previous
Next ❯

Citations

May 23, 2020·Expert Review of Endocrinology & Metabolism·Jeff M P HollyClaire M Perks
Jul 2, 2020·Cancer Management and Research·Hongliang ZhangWei Guo
Sep 11, 2020·Nature Reviews. Cancer·Emily J Gallagher, Derek LeRoith
Dec 18, 2020·International Journal of Molecular Sciences·Fabrizio FontanaPatrizia Limonta
Mar 12, 2021·Frontiers in Endocrinology·Rossella CannarellaAldo E Calogero
Apr 27, 2021·Expert Opinion on Biological Therapy·Aitor González-TitosMacarena Perán
May 1, 2021·Cancers·Miłosz KnuraTomasz Francuz
Mar 4, 2021·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Ville J VihervuoriTeemu J Murtola
Jun 3, 2021·International Journal of Molecular Sciences·Helena OliveresJoan Maurel
Jul 28, 2021·Translational Research : the Journal of Laboratory and Clinical Medicine·Giuseppe BroggiGiorgio Ivan Russo
Jul 30, 2021·Journal of Cellular and Molecular Medicine·Geetha NalairndranChee-Onn Leong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis